World Mental Health Day 2024

October 10, 2024

Celebrating Progress in Mental Health Care

On World Mental Health Day, we reflect on the strides being made in mental health care and the hope that new therapies bring. A recent breakthrough—a safer treatment for agitation in schizophrenia and bipolar disorders—embodies this progress. CRC is proud to have supported the clinical trials that led to FDA approval, staying true to our mission of improving patients’ lives.

Transforming Patient Care Through Collaboration

This new therapy offers a safer, more compassionate way to manage agitation, giving patients and healthcare providers more control in critical moments. The approval underscores the power of teamwork and dedication. Micah Humphrey, one of the many contributors to the project’s success, shared his excitement for this important milestone.

A Lasting Commitment to Global Mental Health


With nearly 970 million people worldwide affected by mental health conditions, CRC is honored to have supported 15 FDA-approved CNS treatments. On this World Mental Health Day, we thank all those working tirelessly to improve mental health. Our shared commitment to advancing life-changing therapies continues to drive us forward.

Check Out the Full Case Study to Learn More

< Older Post

Newer Post >
Principal investigator and clinical research associate

4 Ways Strategic Site Selection Maximizes the Value Equation

April 10, 2025
In clinical trials, success hinges not just on protocol design and quality data but on choosing the right investigative sites and engaging them effectively. Here are four key reasons why strategic site selection is critical for maximizing value in your clinical trials.

Expedited Completion of a Complex Driving Study

March 26, 2025
Driving In the Fast Lane
A damaged car is sitting on the side of the road in the rain.

Next-Day Effects: Are Medications Leaving Drivers at Risk?

December 18, 2024
Since 2018, more than 30 drugs with the potential to impair driving ability have been approved without a dedicated driving study, despite clearly meeting the FDA criteria for such studies based on a conservative application of these criteria.
Show More